Lake Street Capital Cuts ReWalk Robotics (NASDAQ:LFWD) Price Target to $4.50

ReWalk Robotics (NASDAQ:LFWD) had its target price lowered by equities researchers at Lake Street Capital from $6.00 to $4.50 in a research note issued to investors on Thursday,Benzinga reports. The brokerage currently has a “buy” rating on the stock. Lake Street Capital’s price target suggests a potential upside of 145.23% from the stock’s previous close.

LFWD has been the topic of a number of other reports. Laidlaw assumed coverage on ReWalk Robotics in a research report on Monday, February 10th. They set a “buy” rating and a $10.00 price target on the stock. HC Wainwright reaffirmed a “buy” rating and set a $13.00 price objective on shares of ReWalk Robotics in a report on Thursday.

ReWalk Robotics Trading Down 0.3 %

LFWD traded down $0.01 on Thursday, hitting $1.84. 337,060 shares of the stock traded hands, compared to its average volume of 1,333,604. ReWalk Robotics has a 52 week low of $1.25 and a 52 week high of $7.70. The firm has a market capitalization of $19.51 million, a PE ratio of -0.74 and a beta of 2.05. The business has a fifty day moving average price of $1.74 and a two-hundred day moving average price of $2.42.

Insiders Place Their Bets

In other ReWalk Robotics news, major shareholder Global Fund Lp Lind II sold 381,676 shares of the stock in a transaction dated Monday, January 6th. The stock was sold at an average price of $3.36, for a total transaction of $1,282,431.36. Following the completion of the transaction, the insider now owns 1,049,430 shares in the company, valued at approximately $3,526,084.80. This represents a 26.67 % decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link. Also, Director Michael Swinford acquired 16,907 shares of the firm’s stock in a transaction dated Friday, November 22nd. The stock was bought at an average price of $1.83 per share, with a total value of $30,939.81. Following the acquisition, the director now directly owns 43,418 shares in the company, valued at $79,454.94. This represents a 63.77 % increase in their ownership of the stock. The disclosure for this purchase can be found here. In the last quarter, insiders have bought 44,529 shares of company stock valued at $84,972. 2.50% of the stock is currently owned by corporate insiders.

About ReWalk Robotics

ReWalk Robotics Ltd., a medical device company, designs, develops, and commercializes technologies that enable mobility and wellness in rehabilitation and daily life for individuals with physical and neurological conditions in the United States, Europe, the Asia-Pacific, and internationally. It offers ReWalk personal exoskeleton and rehabilitation exoskeleton devices; ReStore, a soft exo-suit intended for use in the rehabilitation of individuals with lower limb disability due to stroke; AlterG Anti-Gravity System for use in physical and neurological rehabilitation and athletic training; MyoCycle devices; and ReBoot, a personal soft exo-suit for home and community use by individuals post-stroke.